New data from the World Health Organization (WHO) warns of a rise in drug-resistant gonorrhea worldwide. According to a news release from the agency’s Enhanced Gonococcal Antimicrobial Surveillance Program, resistance to ceftriaxone and cefixime—2 first-line antibiotics for gonorrhea—has increased. From 2022 to 2024, ceftriaxone resistance rose from 0.8% to 5%, while cefixime resistance rose from 1.7% to 11%. Resistance to azithromycin, which is often used alongside ceftriaxone or cefixime, also increased from 0.5% to 4%, …
Read More